Interaction of prazosin with model membranes - A Langmuir monolayer study

Bioelectrochemistry

Volumn 87, Issue , 2012, Pages 96-103

  Gzyl Malcher, Barbara ^a   Handzlik, Jadwiga ^b   Klekowska, Ewelina ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cholesterol; Langmuir monolayer; Phospholipid; Prazosin; The excess free energy of mixing

Indexed keywords

AIR WATER INTERFACES; DPPC MONOLAYERS; DRUG PENETRATION; EXCESS FREE ENERGY; LANGMUIR MONOLAYERS; MIXED MONOLAYERS; MODEL MEMBRANES; MONOLAYER STABILITY; PRAZOSIN; PURE WATER; SINGLE COMPONENTS; SUBPHASES; SURFACE PRESSURE-AREA; WATER SUBPHASE;

CHOLESTEROL; FREE ENERGY; MIXING; PHOSPHOLIPIDS;

MONOLAYERS;

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; PRAZOSIN; WATER;

ARTICLE; ENERGY; ISOTHERM; LANGMUIR BLODGETT FILM; LIPID MEMBRANE; MOLECULAR INTERACTION; MOLECULAR STABILITY; QUANTITATIVE ANALYSIS; SURFACE PROPERTY; THERMODYNAMICS;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AIR; CHOLESTEROL; HYDROGEN BONDING; MEMBRANES, ARTIFICIAL; MODELS, CHEMICAL; PRAZOSIN; SURFACE PROPERTIES; THERMODYNAMICS; WATER;

EID: 84865193147     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2011.12.005     Document Type: Article

References (44)

1. Bremner J.H., Coban B., Griffith R., Groenewoud K.M., Yates B.F. Ligand design for alpha 1 adrenoceptor subtype selective antagonists. Bioorg. Med. Chem. 2000, 8:201-214.
2. Garcia-Sainz J.A., Vazquez-Prado J., Villalobos-Molina R. Alpha 1-adrenoceptors: subtypes, signaling, and roles in health and disease. Arch. Med. Res. 1999, 30:449-458.
3. Hieble J.P. Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics. Pharm. Acta Helv. 2000, 74:163-171.
4. Docherty J.R. Subtypes of functional α1 and α1-adrenoceptors. Eur. J. Pharmacol. 1998, 361:1-15.
5. Koss M.C. Comparison of peripheral and central nervous system sympatholytic actions of prazosin using the cat nictitating membrane. Eur. J. Pharmacol. 1992, 211:61-67.
6. Pérez O., Valenzuela C., Delpón E., Tamargo J. Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles. Br. J. Pharmacol. 1994, 111:717-722.
7. Ambrosio E., Montero M.T., Fernandez I., Azuara M.C., Orensanz L.M. [3H] prazosin binding to central nervous system regions of male and female rats. Neurosci. Lett. 1984, 49:193-197.
8. Ito T., Hey J.A., Koss M.C. Studies on the mechanism of prazosin induced sympatho-inhibition. Eur. J. Pharmacol. 1988, 158:225-231.
9. Lin S.C., Chueh S.C., Hsiao C.J., Li T.K., Chen T.H., Liao C.H., Lyu P.C., Guh J.H. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle. Neoplasia 2007, 9:830-839.
10. Taylor F.B., Raskind M.A. The a1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J. Clin. Psychopharmacol. 2002, 22:82-85.
11. Dierks M.R., Jordan J.K., Sheehan A.H. Prazosin treatment of nightmares related to posttraumatic stress disorder. Ann. Pharmacother. 2007, 41:1013-1017.
12. Raskind M.A., Peskind E.R., Hoff D.J., Hart K.L., Holmes H.A., Warren D., Shofer J., O'Connell J., Taylor F., Gross C., Rohde K., McFall M.E. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbances in combat veterans with posttraumatic stress disorder. Biol. Psychiatry 2007, 61:928-934.
13. Taylor F.B., Lowe K., Thompson C., McFall M.M., Peskind E.R., Kanter E.D., Allison N., Williams J., Martin P., Raskind M.A. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma PTSD. Biol. Psychiatry 2006, 59:577-581.
14. Ecker G.F., Noe C.R. In silico prediction models for blood-brain barrier permeation. Curr. Med. Chem. 2004, 11:1617-1628.
15. Lipinski C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 2000, 44:235-249.
16. Lodish H., Berk A., Zipursky S.L., Matsudaira P., Baltimore D., Darnell J. Molecular Cell Biology 2000, W.H. Freeman, New York. 4th edition.
17. Paluch M., Gzyl B. Properties of mixed adsorption films of 2,2,2-trichloroethanol-ethanol at the water/air interface. J. Colloid Interface Sci. 1996, 179:51-56.
18. Hossain M.M., Yoshida M., Iimura K., Suzuki N., Kato T. Phase transition in adsorbed monolayers of 2-hydroxyethyl laurate at the air-water interface. Colloids Surf. A 2000, 171:105-113.
19. Vollhardt D., Melzer V. Phase transition in adsorption layers at the air-water interface: bridging to Langmuir monolayers. J. Phys. Chem. B 1997, 101:3370-3375.
20. Gzyl B., Filek M., Dudek A. Influence of phytohormones on polar and hydrophobic parts of mixed phospholipid monolayers at water/air interface. J. Colloid Interface Sci. 2004, 269:153-157.
21. Gzyl-Malcher B., Filek M., Makyła K. Langmuir monolayers of chloroplast membrane lipids. Thin Solid Films 2008, 516:8844-8847.
22. Gzyl-Malcher B., Filek M., Brezesinski G. Influence of cadmium and selenate on the interactions between hormones and phospholipids. Langmuir 2009, 25:13071-13076.
23. Caro A.L., Niño M.R.R., Patino J.M.R. The effect of pH on surface dilatational and shear properties of phospholipid monolayers. Colloids Surf. A 2008, 327:79-89.
24. Peetla C., Stine A., Labhasetwar V. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol. Pharmaceutics 2009, 6:1264-1276.
25. Preetha A., Huilgol N., Banerjee R. Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes. J. Membr. Biol. 2007, 219:83-91.
26. McConlogue C.W., Vanderlick T.K. Monolayers with one component of variable solubility: studies of lysophosphocholine/DPPC mixtures. Langmuir 1998, 14:6556-6562.
27. Gzyl B., Paluch M. Mixed monolayers of dipalmitoyl phosphatidylcholine and ethyl palmitate at the air/water interface. Appl. Surf. Sci. 2005, 246:356-361.
28. Pavinatto A., Pavinatto F.J., Barros-Timmons A., Oliveira O.N. Electrostatic interactions are not sufficient to account for chitosan bioactivity. ACS Appl. Mater. Interfaces 2010, 2:246-251.
29. Slotte J.P. Effect of sterol structure on molecular interactions and lateral domain formation in monolayers containing dipalmitoyl phosphatidylcholine. Biochim. Biophys. Acta 1995, 1237:127-134.
30. Birdi K.S. Lipid and Biopolymer Monolayers at Liquid Interfaces 1989, Plenum Press, New York.
31. Goodrich F.C. Proceedings of the Second International Congress of Surface Activity 1957, vol. 1:85-91. Butterworth, London. J.H. Schulman (Ed.).
32. Gaines G.L. Insoluble Monolayers at Liquid-Gas Interfaces 1966, Interscience Publishers, New York.
33. Vitovič P., Nikolelis D.P., Hianik T. Study of calix[4]resorcinarene-dopamine complexation in mixed phospholipid monolayers formed at the air-water interface. Biochim. Biophys. Acta 2006, 1758:1852-1861.
34. Davies J.T., Rideal E.K. Interfacial Phenomena 1963, Academic Press, New York.
35. Shapovalov V.L. Interaction of DPPC monolayer at air-water interface with hydrophobic ions. Thin Solid Films 1998, 327-329:599-602.
36. Miñones J., Rodríguez Patino J.M., Conde O., Carrera C., Seoane R. The effect of polar groups on structural characteristics of phospholipid monolayers spread at the air-water interface. Colloids Surf. A 2002, 203:273-286.
37. Barrow D.A., Lentz B.R. Membrane structural domains. Resolution limits using diphenylhexatriene fluorescence decay. Biophys. J. 1985, 48:221-234.
38. Ma G., Allen H.C. DPPC Langmuir monolayer at the air-water interface: probing the tail and head groups by vibrational sum frequency generation spectroscopy. Langmuir 2006, 22:5341-5349.
39. Pavinatto F.J., Pacholatti C.P., Montanha E.A., Caseli L., Silva H.S., Miranda P.B., Viitala T., Oliveira O.N. Cholesterol mediates chitosan activity on phospholipid monolayers and Langmuir-Blodgett films. Langmuir 2009, 25:10051-10061.
40. Crisp D.J. A two dimensional phase rule. I. Derivation of a two dimensional phase rule for plane interfaces. Surface Chemistry 1949, 17-22. Butterworths Scientific Publications, London.
41. Almog R., Bems D.S. The role of polar groups in the interaction of dipalmitoylphosphatidylcholine with chlorophyll a in monolayers. J. Colloid Interface Sci. 1981, 81:332-340.
42. Cournia Z., Vaiana A.C., Ullmann G.M., Smith J.C. Derivation of a molecular mechanics force field for cholesterol. Pure Appl. Chem. 2004, 76:189-196.
43. Demel R.A., De Kruyff B. The function of sterols in membranes. Biochim. Biophys. Acta 1976, 457:109-132.
44. Presti F.T. The role of cholesterol in regulating membrane fluidity. Membrane Fluidity in Biology: Cellular Aspects 1985, vol. 4:97-146. Academic Press, New York. R.C. Aloia, J.M. Boggs (Eds.).